Clinical Trial Update: Sodium Glucose Co-transporter (SGLT) Inhibitors in Nonobstructive Hypertrophic Cardiomyopathy [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial evaluating sodium-glucose cotransporter (SGLT) inhibitors for nonobstructive hypertrophic cardiomyopathy; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• SGLT inhibitors

Snippet

Sponsor: University of Pennsylvania | Conditions: Hypertrophic Cardiomyopathy Without Obstruction | EARLY_Phase 1 | Status: RECRUITING